Messina Nena, Burdon William, Hagopian Garo, Prendergast Michael
UCLA Integrated Substance Abuse Programs, Criminal Justice Research Group, 1640 S. Sepulveda Boulevard, Ste. 200, Los Angeles, CA 90025, USA.
Behav Sci Law. 2004;22(4):503-18. doi: 10.1002/bsl.600.
The extent to which therapeutic community (TC) methods meet the treatment needs of offenders with substance abuse disorders and co-occurring psychiatric disorders in prison is largely unknown. Very little research has been conducted with this population. The purposes of this study were to generate profiles of co-disordered drug offenders entering TC treatment in prison and to assess their post-release reincarceration rates, compared with drug offenders without psychiatric disorders. Extensive intake interview data for over 8,500 men and women who received treatment in one of 16 prison-based TCs in California were analyzed to produce profiles of co-disordered participants. Intake data come from a 5 year process and outcome evaluation of the California Department of Corrections' (CDC's) treatment initiative. Post-release reincarceration rates come from the CDC's Offender Based Information System. Compared with non-psychiatric disordered drug offenders, co-disordered offenders had substantially more severe substance abuse and criminal histories, in addition to their psychiatric impairment, at treatment entry. Logistic regression results indicated that, compared with drug offenders without psychiatric illness, co-disordered offenders were significantly more likely to be reincarcerated during the first year of their parole. These results suggest that prison treatment programs may need to use more comprehensive diagnostic assessments at intake to assess the diverse mental health needs of drug offenders with co-occurring psychiatric disorders and to develop treatment approaches suitable for this population.
治疗社区(TC)方法在多大程度上满足监狱中患有药物滥用障碍和并发精神疾病的罪犯的治疗需求,目前很大程度上尚不清楚。针对这一人群开展的研究非常少。本研究的目的是描绘进入监狱TC治疗的共病药物罪犯的概况,并评估他们与无精神疾病的药物罪犯相比的释放后再监禁率。分析了加利福尼亚州16个基于监狱的TC中接受治疗的8500多名男性和女性的大量入院访谈数据,以生成共病参与者的概况。入院数据来自加利福尼亚州惩教部(CDC)治疗计划的为期5年的过程和结果评估。释放后再监禁率来自CDC的基于罪犯的信息系统。与无精神疾病的药物罪犯相比,共病罪犯在进入治疗时除了有精神障碍外,还有更严重的药物滥用和犯罪史。逻辑回归结果表明,与无精神疾病的药物罪犯相比,共病罪犯在假释的第一年再次被监禁的可能性显著更高。这些结果表明,监狱治疗项目可能需要在入院时使用更全面的诊断评估,以评估患有并发精神疾病的药物罪犯的各种心理健康需求,并制定适合这一人群的治疗方法。